SCHEMBL21819159

SCHEMBL21819159

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H](O)[C@H]1OCS

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.73
▸ ADORA1 P30542 2/20 0.73
▸ PI4KA P42356 2/20 0.73
▸ PI4K2B Q8TCG2 2/20 0.73
▸ PI4K2A Q9BTU6 2/20 0.73
▸ PI4KB Q9UBF8 2/20 0.73
▸ DPP4 P27487 1/20 0.73
▸ MEN1 O00255 1/20 0.73
▸ SLC28A1 O00337 1/20 0.73
▸ MAP3K7 O43318 1/20 0.73
▸ SLC28A2 O43868 1/20 0.73
▸ GAPDH P04406 1/20 0.73
▸ MAPK1 P28482 1/20 0.73
▸ ADORA2A P29274 1/20 0.73
▸ ADORA2B P29275 1/20 0.73
▸ STAT6 P42226 1/20 0.73
▸ KMT2A Q03164 1/20 0.73
▸ SMN1; SMN2 Q16637 1/20 0.73
▸ DOT1L Q8TEK3 1/20 0.73
▸ SLC29A1 Q99808 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23928781 0.93 ADORA3 (0.72) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL28991005 0.93 ADORA3 (0.72) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL30274521 0.93 ADORA3 (0.72) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL28991009 0.93 ADORA3 (0.72) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL28804979 0.92 ADORA3 (0.75) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL7611755 0.91 ADORA3 (0.73) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL16174422 0.91 ADORA3 (0.73) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL14424485 0.91 ADORA3 (0.73) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL7611746 0.91 ADORA3 (0.73) ADORA3ADORA1PI4KAPI4K2BPI4K2A
SCHEMBL6898326 0.90 ADORA3 (0.72) ADORA3ADORA1PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11918644-B2 Varicella zoster virus (VZV) vaccine MODERNATX, INC. (US) 2024-03-05 — — US disclosed
US-20230323371-A1 POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE MODERNATX, INC. 2023-10-12 — — US disclosed
US-20220409720-A1 VARICELLA ZOSTER VIRUS (VZV) VACCINE MODERNATX, INC. (US) 2022-12-29 — — US disclosed
US-11421011-B2 Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof MODERNATX, INC. (US) 2022-08-23 — — US disclosed
US-20220047518-A1 PEG LIPIDS AND USES THEREOF Moderna TX, Inc. (US) 2022-02-17 — — US disclosed
US-20210206818-A1 MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF MODERNATX, INC. 2021-07-08 — — US disclosed
US-11003366-B2 Methods of using OX40 ligand encoding polynucleotides MODERNATX, INC. (US) 2021-05-11 — — US disclosed
US-20200102363-A1 POLYNUCLEOTIDES ENCODING TETHERED INTERLEUKIN-12 (IL12) POLYPEPTIDES AND USES THEREOF MODERNATX, INC. (US) 2020-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11421011-B2 Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof IL2, PRR12, IL2RA ADORA3 4297/4885ADORA1 4360/4885PI4KA 1626/4885
US-20220047518-A1 PEG LIPIDS AND USES THEREOF LIPA, LIPG, LNPEP ADORA3 4579/4885ADORA1 4735/4885PI4KA 1904/4885
US-20220409720-A1 VARICELLA ZOSTER VIRUS (VZV) VACCINE RNMT, VAC14, IRF3 ADORA3 3810/4885ADORA1 4377/4885PI4KA 1587/4885
US-20200102363-A1 POLYNUCLEOTIDES ENCODING TETHERED INTERLEUKIN-12 (IL12) POLYPEPTIDES AND USES THEREOF IL2, PRR12, IL2RA ADORA3 4297/4885ADORA1 4360/4885PI4KA 1626/4885
US-20230323371-A1 POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE GBA1, GAA, GLA ADORA3 2097/4885ADORA1 4004/4885PI4KA 1255/4885
US-11918644-B2 Varicella zoster virus (VZV) vaccine RNMT, VAC14, IRF3 ADORA3 3810/4885ADORA1 4377/4885PI4KA 1587/4885
US-20210206818-A1 MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF PABPC4, HNRNPAB, PABPC1 ADORA3 3304/4885ADORA1 4170/4885PI4KA 1915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback